CTT PHARMACEUTICAL HOLDINGS, INC. Insider Trading Activity
Every SEC Form 4 transaction reported by CTT PHARMACEUTICAL HOLDINGS, INC., sourced directly from SEC EDGAR and updated as new filings are accepted.
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is CTT PHARMACEUTICAL HOLDINGS, INC. buying or selling?
CTT PHARMACEUTICAL HOLDINGS, INC. reported 61 open-market buys ($54.0K) and 0 sells ($0) across 61 Form 4 filings at 1 company — a net buying position of $54.0K.
Source: SEC EDGAR Form 4
Key Statistics (as of Oct 6, 2026)
Insider sentiment
Net buyingNet insider flow of $54.0K in net buying, filed between Jan 30, 2023 – Oct 6, 2026.
Companies CTT PHARMACEUTICAL HOLDINGS, INC. files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | CTTHCTT PHARMACEUTICAL HOLDINGS, INC. | 61 |
Recent CTT PHARMACEUTICAL HOLDINGS, INC. transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | CTTH | CEO | Purchase | 3.7K | $203.5 | SEC ↗ |
| Sep 29, 2026 | CTTH | CEO | Purchase | 10.1K | $454.5 | SEC ↗ |
| Sep 28, 2026 | CTTH | CEO | Purchase | 3.4K | $187 | SEC ↗ |
| Sep 22, 2026 | CTTH | CEO | Purchase | 10.1K | $454.5 | SEC ↗ |
| Sep 16, 2026 | CTTH | CEO | Purchase | 10.9K | $523.2 | SEC ↗ |
| Sep 10, 2026 | CTTH | CEO | Purchase | 3.5K | $175 | SEC ↗ |
| Sep 4, 2026 | CTTH | CEO | Purchase | 9.8K | $479.22 | SEC ↗ |
| Sep 2, 2026 | CTTH | CEO | Purchase | 3.0K | $146.7 | SEC ↗ |
| Aug 31, 2026 | CTTH | CEO | Purchase | 3.5K | $171.5 | SEC ↗ |
| Aug 25, 2026 | CTTH | CEO | Purchase | 2.1K | $115.5 | SEC ↗ |
| Aug 20, 2026 | CTTH | CEO | Purchase | 11.5K | $517.5 | SEC ↗ |
| Aug 19, 2026 | CTTH | CEO | Purchase | 10.0K | $590 | SEC ↗ |
| Aug 14, 2026 | CTTH | CEO | Purchase | 1.8K | $111.6 | SEC ↗ |
| Aug 10, 2026 | CTTH | CEO | Purchase | 7.7K | $500.5 | SEC ↗ |
| Dec 17, 2025 | CTTH | CEO | Purchase | 8.3K | $456.5 | SEC ↗ |
| Nov 24, 2025 | CTTH | Director | Purchase | 200.0K | $8.0K | SEC ↗ |
| Nov 21, 2025 | CTTH | CEO | Purchase | 62.9K | $2.5K | SEC ↗ |
| Oct 31, 2025 | CTTH | CEO | Purchase | 7.0K | $420 | SEC ↗ |
| Oct 7, 2025 | CTTH | CEO | Purchase | 6.8K | $408.9 | SEC ↗ |
| Sep 23, 2025 | CTTH | CEO | Purchase | 44.1K | $2.0K | SEC ↗ |
| Aug 1, 2025 | CTTH | CEO | Purchase | 15.8K | $553 | SEC ↗ |
| Jul 8, 2025 | CTTH | CEO | Purchase | 8.0K | $240 | SEC ↗ |
| Jun 30, 2025 | CTTH | CEO | Purchase | 39.6K | $990 | SEC ↗ |
| Jun 23, 2025 | CTTH | CEO | Purchase | 16.1K | $402.5 | SEC ↗ |
| Jun 13, 2025 | CTTH | CEO | Purchase | 54.8K | $1.4K | SEC ↗ |
Showing the 25 most recent filings of 61. Screen every filing.
CTT PHARMACEUTICAL HOLDINGS, INC. insider trading FAQ
Is CTT PHARMACEUTICAL HOLDINGS, INC. buying or selling?
Across 61 SEC Form 4 filings, CTT PHARMACEUTICAL HOLDINGS, INC. reported 61 open-market purchases totaling $54.0K and 0 sales totaling $0 — a net buying position of $54.0K.
Which companies does CTT PHARMACEUTICAL HOLDINGS, INC. file Form 4s for?
CTT PHARMACEUTICAL HOLDINGS, INC. has reported insider transactions at 1 company, most often CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH).
How far back does CTT PHARMACEUTICAL HOLDINGS, INC.'s filing history go?
Trabud holds CTT PHARMACEUTICAL HOLDINGS, INC.'s SEC Form 4 filings from Jan 30, 2023 – Oct 6, 2026, sourced directly from SEC EDGAR.
Where does Trabud get CTT PHARMACEUTICAL HOLDINGS, INC.'s insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track CTT PHARMACEUTICAL HOLDINGS, INC. and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener